The inclusion of PRS in predictive models for the transition to AD in individuals with mild cognitive decline improves the model compared to models based on APOE alone, with the AUC increasing from 0.68 to 0.84 [183,184]. The gene discussed is APOE; the disease is Alzheimer disease.